Replies to post #183241 on Biotech Values

[north40000]

What % of biotech or pharma companies publish how many patients are involved in a clinical trial on a daily, seriatim basis?

[Robert C Jonson]

At the ASM 2 weeks ago the CEO told us they would only PR enrollment data if the numbers differed substantially from the announced 2yr enrollment plan. He said to use how quickly the interim peeks occur as an indicator of their pace of enrollment, since they are event-driven. He and Dr. Shan have also gone to many, if not most of their enrollment sites to talk with the doctors there, which apparently is a very unusual thing to do.

So, although you may be concerned about enrollment, at this point I'm not.

Bob

[geocappy1]

We’ll never find out, if PPHM can’t get patients to enroll in the SUNRISE trial.

Please provide some backup (proof) for this statement. It is industry standard not to announce enrollment unless completed. To announce ongoing enrollment numbers is the exception and not the norm.